ArticleCancer communications (London, England)2024

Acquired RD3 loss regulates immune surveillance in high-risk and therapy defying progressive neuroblastoma.

Poorvi Subramanian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.